|
|
|
Insider
Information: |
Luo Mary Z. |
Relationship: |
COO,Chief Scientist & ... |
City: |
Rancho Cucamonga |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
2,433,554 |
|
Indirect Shares
|
8,057,435 |
|
|
Direct
Value |
$102,574,301 |
|
|
Indirect Value
|
$339,620,885 |
|
|
Total
Shares |
10,490,989 |
|
|
Total
Value |
$442,195,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$163,932 |
I/I |
(8,890) |
1,431,479 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2018-03-26 |
4 |
D |
$18.61 |
$164,587 |
I/I |
(8,844) |
1,346,129 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-15 |
4 |
D |
$34.74 |
$166,266 |
I/I |
(4,786) |
1,515,997 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4 |
OE |
$12.97 |
$166,794 |
D/D |
12,860 |
924,496 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4/A |
OE |
$12.97 |
$166,794 |
D/D |
12,860 |
936,241 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4/A |
OE |
$12.97 |
$167,702 |
I/I |
12,930 |
687,662 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4 |
OE |
$12.97 |
$167,702 |
I/I |
12,930 |
674,596 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4 |
OE |
$12.97 |
$168,286 |
D/D |
12,975 |
924,611 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4/A |
OE |
$12.97 |
$168,286 |
D/D |
12,975 |
935,112 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
|
2021-03-15 |
4 |
D |
$19.15 |
$183,687 |
I/I |
(9,592) |
1,440,369 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4/A |
AS |
$16.37 |
$186,820 |
I/I |
(11,411) |
674,732 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4 |
AS |
$16.37 |
$186,820 |
I/I |
(11,411) |
662,874 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2016-03-26 |
4 |
D |
$11.96 |
$187,904 |
D/D |
(15,711) |
1,114,191 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2018-03-17 |
4 |
D |
$19.91 |
$190,917 |
I/I |
(9,589) |
1,354,973 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4 |
AS |
$16.47 |
$191,045 |
D/D |
(11,600) |
912,896 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4/A |
AS |
$16.47 |
$191,045 |
D/D |
(11,600) |
924,641 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4 |
AS |
$16.47 |
$192,093 |
I/I |
(11,664) |
662,932 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-11 |
4/A |
AS |
$16.47 |
$192,093 |
I/I |
(11,664) |
675,998 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4 |
AS |
$16.38 |
$192,144 |
D/D |
(11,731) |
912,880 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
|
2015-06-10 |
4/A |
AS |
$16.38 |
$192,144 |
D/D |
(11,731) |
923,381 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-11 |
4 |
AS |
$14.05 |
$211,736 |
I/I |
(15,066) |
7,461,594 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
|
2015-12-07 |
4 |
AS |
$14.59 |
$219,490 |
I/I |
(15,046) |
7,549,253 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
|
2019-03-16 |
4 |
D |
$20.23 |
$239,361 |
I/I |
(11,832) |
1,412,963 |
0 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
|
2018-05-16 |
4 |
B |
$16.06 |
$240,854 |
D/D |
15,000 |
2,080,619 |
3.23 |
- |
|
AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
|
2022-03-17 |
4 |
D |
$34.18 |
$241,037 |
I/I |
(7,052) |
1,498,519 |
0 |
- |
|
170 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|